Patients with bullous pemphigoid and comorbid psoriasis present with less blisters and lower serum levels of anti‐BP180 autoantibodies
Journal of the European Academy of Dermatology and Venereology | Oct 28, 2020
Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52‐week results from a Phase 3 double‐blind randomised, controlled trial
Journal of the European Academy of Dermatology and Venereology | Oct 21, 2020
IgE autoantibodies in serum and skin of nonbullous and bullous pemphigoid patients
Journal of the European Academy of Dermatology and Venereology | Oct 20, 2020